236 related articles for article (PubMed ID: 31821340)
41. IL-18 and related function proteins associated with tuberculosis severity and screening for active TB among patients with non-mycobacterial community-acquired pneumonia (CAP).
Wawrocki S; Seweryn M; Kielnierowski G; Rudnicka W; Druszczynska M
Saudi J Biol Sci; 2020 Nov; 27(11):3035-3045. PubMed ID: 33100863
[TBL] [Abstract][Full Text] [Related]
42. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
[TBL] [Abstract][Full Text] [Related]
43. Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in Tanzania.
Drabe CH; Vestergaard LS; Helleberg M; Nyagonde N; Rose MV; Francis F; Theilgaard OP; Asbjørn J; Amos B; Bygbjerg IC; Ruhwald M; Ravn P
Am J Trop Med Hyg; 2016 Apr; 94(4):728-35. PubMed ID: 26834199
[TBL] [Abstract][Full Text] [Related]
44. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis.
Goletti D; Raja A; Ahamed Kabeer BS; Rodrigues C; Sodha A; Butera O; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH
J Infect; 2010 Jul; 61(2):133-43. PubMed ID: 20470822
[TBL] [Abstract][Full Text] [Related]
45. The assessment of cytokines in Quantiferon supernatants for the diagnosis of latent TB infection in a tribal population of Melghat, India.
Bapat PR; Husain AA; Daginawala HF; Agrawal NP; Panchbhai MS; Satav AR; Taori GM; Kashyap RS
J Infect Public Health; 2015; 8(4):329-40. PubMed ID: 25824629
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic performance of GM-CSF and IL-2 in response to long-term specific-antigen cell stimulation in patients with active and latent tuberculosis infection.
Balcells ME; Ruiz-Tagle C; Tiznado C; García P; Naves R
Tuberculosis (Edinb); 2018 Sep; 112():110-119. PubMed ID: 30205963
[TBL] [Abstract][Full Text] [Related]
47. Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study.
Zhang L; Cheng X; Bian S; Song Y; Li Q; Gao M; Zhang Y; Shi X; Liu X
PLoS One; 2017; 12(5):e0177850. PubMed ID: 28531231
[TBL] [Abstract][Full Text] [Related]
48. QuantiFERON-TB Gold Plus Assay in Patients With Latent vs. Active Tuberculosis in a Low Incidence Setting: Level of IFN-γ, CD4/CD8 Responses, and Release of IL-2, IP-10, and MIG.
Carrère-Kremer S; Kolia-Diafouka P; Pisoni A; Bolloré K; Peries M; Godreuil S; Bourdin A; Van de Perre P; Tuaillon E
Front Microbiol; 2022; 13():825021. PubMed ID: 35464936
[TBL] [Abstract][Full Text] [Related]
49. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10.
Ruhwald M; Petersen J; Kofoed K; Nakaoka H; Cuevas LE; Lawson L; Squire SB; Eugen-Olsen J; Ravn P
PLoS One; 2008 Aug; 3(8):e2858. PubMed ID: 18682747
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the QuantiFERON?-TB Gold In-Tube assay and tuberculin skin test for the diagnosis of Mycobacterium tuberculosis infection in northeastern Thailand.
Reechaipichitkul W; Pimrin W; Bourpoern J; Prompinij S; Faksri K
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):236-44. PubMed ID: 26342121
[TBL] [Abstract][Full Text] [Related]
51. Ethnicity-tailored novel set of ESAT-6 peptides for differentiating active and latent tuberculosis.
Singh SB; Biswas D; Rawat J; Sindhwani G; Patras A; Devrani S; Sarkar P; Mitra S; Gupta SK
Tuberculosis (Edinb); 2013 Nov; 93(6):618-24. PubMed ID: 24011630
[TBL] [Abstract][Full Text] [Related]
52. Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection.
Xiao JN; Xiong Y; Chen Y; Xiao YJ; Ji P; Li Y; Wang SJ; Zhao GP; Cheng QJ; Lu SH; Wang Y
Front Cell Infect Microbiol; 2017; 7():495. PubMed ID: 29250493
[TBL] [Abstract][Full Text] [Related]
53. Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis.
Kamakia R; Kiazyk S; Waruk J; Meyers A; Ochanda J; Ball TB; Oyugi J
Int J Tuberc Lung Dis; 2017 Mar; 21(3):278-285. PubMed ID: 28225338
[TBL] [Abstract][Full Text] [Related]
54. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis.
Ruhwald M; Bodmer T; Maier C; Jepsen M; Haaland MB; Eugen-Olsen J; Ravn P;
Eur Respir J; 2008 Dec; 32(6):1607-15. PubMed ID: 18684849
[TBL] [Abstract][Full Text] [Related]
55. Boosting effect of IL-7 in interferon gamma release assays to diagnose Mycobacterium tuberculosis infection.
Hiza H; Fenner L; Hella J; Kuchaka D; Sasamalo M; Blauenfeldt T; Kibiki G; Kavishe RA; Mhimbira F; Ruhwald M
PLoS One; 2018; 13(8):e0202525. PubMed ID: 30157233
[TBL] [Abstract][Full Text] [Related]
56. Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB.
Wang S; Li Y; Shen Y; Wu J; Gao Y; Zhang S; Shao L; Jin J; Zhang Y; Zhang W
J Transl Med; 2018 Jul; 16(1):206. PubMed ID: 30029650
[TBL] [Abstract][Full Text] [Related]
57. Levels of vitamin D-associated cytokines distinguish between active and latent tuberculosis following a tuberculosis outbreak.
Hong Y; Kim Y; Lee JJ; Lee MG; Lee CY; Kim Y; Heo J; Han SS; Lee SJ; Kim WJ; Hong JY
BMC Infect Dis; 2019 Feb; 19(1):151. PubMed ID: 30760247
[TBL] [Abstract][Full Text] [Related]
58. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
[TBL] [Abstract][Full Text] [Related]
59. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
[TBL] [Abstract][Full Text] [Related]
60. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
